Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Thyroid Neoplasms × Neck Dissection × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Oropharyngeal Neoplasms 1 Head and Neck Neoplasms 1

Interventions

selpercatinib 4 pembrolizumab 4 trametinib 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 durvalumab 2 dabrafenib 2 cabozantinib 2 Vemurafenib 2 Sorafenib 2 Immunoglobulin G 2 Disulfides 2 Bevacizumab 2 tipifarnib 1 temsirolimus 1 spartalizumab 1 regorafenib 1 naporafenib 1 lenvatinib 1 encorafenib 1 cobimetinib 1 binimetinib 1 atezolizumab 1 Valproic Acid 1 Transurethral Resection of Prostate 1 Taxes 1 Surgical Procedures, Operative 1 Specimen Handling 1 Sodium Iodide 1 Sirolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03570021 2026-03-06

ESTIMABL3

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Active not recruiting

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡